Drug Development Stakeholder Register
This is a practical guide to building a stakeholder register for a drug development project — a record of stakeholders, their influence and how to engage them, adapted to the realities of developing a pharmaceutical product through regulatory stages.
What a Stakeholder Register is
A stakeholder register is a record of stakeholders, their influence and how to engage them. For the full concept and how it works in general, see Stakeholder Register. On a drug development project it plays the same role, tuned to this kind of work.
Why it matters for a Drug Development project
Drug Development projects live or die on developing a pharmaceutical product through regulatory stages. A well-built stakeholder register gives the team a shared, explicit reference for exactly that — reducing ambiguity, aligning stakeholders, and making problems visible early enough to act. Skipping it, or doing it generically, is how drug development projects drift into avoidable delay and cost.
What to include
- Stakeholder name and role
- Power and interest
- Attitude
- Engagement approach
Drug Development-specific considerations
Tailor the stakeholder register to the risks that most often derail drug development projects:
- Regulatory approval delays
- Trial/validation failures
- Strict GxP compliance
Example
On a real drug development project, the stakeholder register would be shaped by developing a pharmaceutical product through regulatory stages. In particular, it should explicitly account for the project’s biggest risks — regulatory approval delays, trial/validation failures, strict GxP compliance — rather than treating them as afterthoughts.